Cerebral small vessel disease, hypertension, and vascular contributions to cognitive impairment and dementia

AH Hainsworth, HS Markus, JA Schneider - Hypertension, 2024‏ - ahajournals.org
Hypertension-associated cerebral small vessel disease is a common finding in older people.
Strongly associated with age and hypertension, small vessel disease is found at autopsy in …

Antithrombotic Therapy for Primary and Secondary Prevention of Ischemic Stroke: JACC State-of-the-Art Review

A Greco, G Occhipinti, D Giacoppo, F Agnello… - Journal of the American …, 2023‏ - jacc.org
Stroke is a devastating condition with significant morbidity and mortality worldwide.
Antithrombotic therapy plays a crucial role in both primary and secondary prevention of …

Tetrazole derivatives in the management of neurological disorders: Recent advances on synthesis and pharmacological aspects

S Jaiswal, K Verma, J Dwivedi, S Sharma - European Journal of Medicinal …, 2024‏ - Elsevier
Neurological disorders are the leading cause of a large number of mortalities and
morbidities. Nitrogen heterocyclic compounds have been pivotal in exhibiting wide array of …

Cerebrovascular effects of sildenafil in small vessel disease: the OxHARP trial

AJS Webb, JS Birks, KA Feakins, A Lawson… - Circulation …, 2024‏ - ahajournals.org
BACKGROUND: Vascular cognitive impairment due to cerebral small vessel disease is
associated with cerebral pulsatility, white matter hypoperfusion, and reduced …

The role of cilostazol, a phosphodiesterase-3 inhibitor, in the development of atherosclerosis and vascular biology: a review with meta-analysis

M Sohn, S Lim - International Journal of Molecular Sciences, 2024‏ - mdpi.com
Atherosclerotic cardiovascular disease (ASCVD) stands as the leading global cause of
mortality. Addressing this vital and pervasive condition requires a multifaceted approach, in …

Associations between neurovascular coupling and cerebral small vessel disease: a systematic review and meta-analysis

S Yang, AJS Webb - European Stroke Journal, 2023‏ - journals.sagepub.com
Purpose: The pathogenesis of cerebral small vessel disease (cSVD) remains elusive
despite evidence of an association between white matter hyperintensities (WMH) and …

Current and future treatments of vascular cognitive impairment

BYM Ip, H Ko, BYK Lam, LWC Au, AYL Lau, J Huang… - Stroke, 2024‏ - ahajournals.org
Vascular cognitive impairment (VCI) traditionally encompasses a variety of cerebrovascular
pathologies that contribute to varying levels of cognitive impairment, ranging from subtle to …

[HTML][HTML] A sco** review on biomarkers of endothelial dysfunction in small vessel disease: molecular insights from human studies

D Jaime Garcia, A Chagnot, JM Wardlaw… - International Journal of …, 2023‏ - mdpi.com
Small vessel disease (SVD) is a highly prevalent disorder of the brain's microvessels and a
common cause of dementia as well as ischaemic and haemorrhagic strokes. Though much …

Advances in nitric oxide regulators for the treatment of ischemic stroke

J Wu, J Jia, D Ji, W Jiao, Z Huang, Y Zhang - European Journal of …, 2023‏ - Elsevier
Ischemic stroke (IS) is a life-threatening disease worldwide. Nitric oxide (NO) derived from l-
arginine catalyzed by NO synthase (NOS) is closely associated with IS. Three isomers of …

Endothelial cells as key players in cerebral small vessel disease

R Kremer, A Williams, J Wardlaw - Nature Reviews Neuroscience, 2025‏ - nature.com
Cerebral small vessel disease (SVD) is a vascular disorder that increases the risk of stroke
and dementia and is diagnosed through brain MRI. Current primary prevention and …